Living Between Scans: Uncertainty, Hope and Life After a Dementia Diagnosis
In this guest article, ADI Board Member and dementia advocate, Bill Yeates, shares his post diagnosis journey, discussing the hopes and challenges of life between scans.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
ADI Launches the Alzheimer’s Disease Atlas
Access the world's first of its kind platform highlighting how countries diagnose, treat and support people living with dementia.
Dementia policy in Uruguay: Advancing a national dementia plan and ECLAC’s regional action
Highlighting Uruguay's advancements in dementia policy in August 2026: from ADI's high-level meeting with the Minister of Public Health, to joining the Economic Commission for Latin America and the Caribbean's Regional Conference on Population and Development.
New Alzheimer’s blood test to detect Alzheimer’s pathology gains FDA approval
Updates on recent blood tests including Elecsys® pTau217, developed by Roche in collaboration with Eli Lilly, as well as the Lumipulse G pTau 217 Plasma assay by Fujirebio Europe N.V.
Action, progression and collaboration towards national dementia plans in the Americas
July has seen increasing progression and activity towards the development of national dementia plans in the Americas region, from Colombia's first step towards a national dementia law to knowledge-sharing initiatives between Chile, Ecuador and Argentina, with regional collaboration playing an increasingly important role in advancing dementia policy across Latin America.
Highlights from the National Dementia Plan Pan Regional Workshop 2026
Government representatives, dementia associations and WHO experts gathered in London to share progress, tackle challenges and strengthen collaboration on developing and implementing effective National Dementia Plans worldwide.
ADI attends the 79th World Health Assembly
Highlights from the 79th World Health Assembly, a round-up of ADI's engagements at the annual gathering at WHO Headquarters, Geneva, Switzerland.
People living with dementia and their families need clear guidance when weighing choices of new Alzheimer’s treatments
A commentary in response to the recent Cochrane review of clinical trial data on different anti-amyloid treatments, that states these medicines show ‘no clinically meaningful benefit’ for people with Alzheimer’s.
Americas takes Action in April; From regional declarations to national advocacy
In April, there has been a plethora of activity around dementia and brain health policy, as governments, regional bodies, and civil society strengthen collaboration to address one of the region’s fastest-growing public health challenges.
Highlights from the 37th Global Conference of ADI
The 37th Global Conference of Alzheimer’s Disease International (ADI 2026) brought together a truly global collective in Lyon, uniting over 1,500 delegates from more than 90 countries. With 1,133 abstracts submitted and 672 posters presented, the conference showcased the breadth of innovation, research and collaboration shaping the future of dementia…